Shay Golan

University of Chicago, Tel Aviv University

Papers

7

Total Citations

287

H-Index

7

About

Shay Golan is a urologic oncologist whose research focuses on advancing minimally invasive surgical techniques for kidney, testicular, and prostate cancers. He has made significant contributions to the field of robotic-assisted surgery, particularly in demonstrating the safety and early oncologic effectiveness of primary robotic retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer, a study that has garnered 115 citations. Golan’s work also addresses critical questions in nephron-sparing surgery, including the differential use of partial nephrectomy for complex renal tumors and the development of care pathways enabling early discharge after laparoscopic or robotic partial nephrectomy. His innovative research extends to prostate cancer, where he led a phase 1 trial investigating neoadjuvant 177Lu-PSMA-I&T radionuclide treatment before radical prostatectomy, opening new avenues for targeted therapy. Additionally, Golan has examined temporal trends in perioperative morbidity for radical cystectomy using national databases, providing valuable insights into surgical quality improvement. With over 280 citations across his most-cited works, Golan’s research has helped refine surgical standards and expand treatment options for urologic cancers.

Research Focus

Key Achievements

7
H-Index
7
Papers
287
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer
115 citations · 2016
📈 Most Prolific Year: 2013 (3 Papers)
🤝 Key Collaborators: 46
🏛 Institutions: University of Chicago, Tel Aviv University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago